XBIT stock forecast
Our latest prediction for XBiotech, Inc.'s stock price was made on the June 4, 2019 when the stock price was at 7.12$.
In the short term (2weeks), XBIT's stock price should outperform the market by 4.75%. During that period the price should oscillate between -7.92% and +15.27%.
In the medium term (3months), XBIT's stock price should outperform the market by 4.55%. During that period the price should oscillate between -18.01% and +36.02%.
Get email alertsAbout XBiotech, Inc.
XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.64$ per share.
The book value per share is 1.44$
Three months stock forecastJune 4, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -23M | - | -23M | -0.64 | - | - | 36M | 1.44 | -18M | - | -18M |